Results 11 to 20 of about 75,972 (251)
Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use [PDF]
Emerging Infectious Diseases, 2005 Few long-term multicenter investigations have evaluated the relationships between aggregate antimicrobial drug use in hospitals and bacterial resistance. We measured fluoroquinolone use from 1999 through 2003 in a network of US hospitals. The percentages
Conan MacDougall +5 more
doaj +2 more sources
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use [PDF]
Interdisciplinary Perspectives on Infectious Diseases, 2012 This paper on the fluoroquinolone resistance epidemiology stratifies the data according to the different prescription patterns by either primary or tertiary caregivers and by indication.
Axel Dalhoff
doaj +2 more sources
Fluoroquinolone-resistant Escherichia coli, Indonesia [PDF]
, 2005 In a recent, population-based survey of 3,996 persons in Indonesia, fluoroquinolone (FQ)-resistant Escherichia coli was prevalent in the fecal flora of 6% of patients at hospital admission and 23% of patients at discharge, but not among healthy ...
Mertaniasih, Ni Made +31 more
core +2 more sources
Cardiotoxicity of fluoroquinolones [PDF]
Journal of Antimicrobial Chemotherapy, 2002 Currently marketed fluoroquinolones enjoy an admirable safety profile that is not matched by any other antibiotic group. The widespread use of fluoroquinolones in the elderly, who are susceptible to cardiac arrhythmias because of underlying heart diseases, metabolic derangement and use of anti-arrhythmic agents and other medications that prolong the QT
Ethan, Rubinstein, John, Camm
openaire +2 more sources
Revista Española de Quimioterapia, 2023 Fluoroquinolones (FQs) are one of the most commonly prescribed classes of antibiotics. Although they were initially well tolerated in randomized clinical trials, subsequent epidemiological studies have reported an increased risk of threatening, severe, long-lasting, disabling and irreversible adverse effects (AEs), related to neurotoxicity and collagen
José Barberán +6 more
openaire +2 more sources
Pharmacodynamics of Fluoroquinolones [PDF]
Clinical Infectious Diseases, 1998 Fluoroquinolone antimicrobial agents are highly active against aerobic or facultative gram-negative bacilli. The fluoroquinolones have been shown to be very concentration dependent in their rates of killing and also have a postantibiotic effect against most gram-negative pathogens.
H, Lode, K, Borner, P, Koeppe
openaire +2 more sources
, 2021 BACKGROUND: Mycoplasma genitalium was recently added to the CDC's antimicrobial resistance threats 'watch list', as it has rapidly become resistant to mainstay treatments.
Bletchly, Cheryl +4 more
core +1 more source
Fluoroquinolone antibiotics and tendon injury in adolescents [PDF]
, 2021 OBJECTIVES: To estimate the association between fluoroquinolone use and tendon injury in adolescents. METHODS: We conducted an active-comparator, new-user cohort study using population-based claims data from 2000 to 2018. We included adolescents (aged 12-
Funk, M.J +4 more
core +1 more source
PLoS ONE, 2014 Antibiotic resistance in Streptococcus pneumoniae has increased worldwide by the spread of a few clones. Fluoroquinolone resistance occurs mainly by alteration of their intracellular targets, the type II DNA topoisomerases, which is acquired either by ...
Elena López +8 more
doaj +1 more source
Antibiotics, 2023 Background: Treatment of device-related infections by drug-resistant Staphylococcus aureus can be challenging, and combination therapy has been proposed as a potential solution.
Yu Ri Kang +6 more
doaj +1 more source